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Abstract
Tuberculosis (TB), caused by Mycobacterium tuberculosis (Mtb), is an enduring public health problem globally, particularly in
sub-Saharan Africa. Several studies have suggested a role for host genetic susceptibility in increased risk for TB but results
across studies have been equivocal. As part of a household contact study of Mtb infection and disease in Kampala, Uganda,
we have taken a unique approach to the study of genetic susceptibility to TB, by studying three phenotypes. First, we
analyzed culture confirmed TB disease compared to latent Mtb infection (LTBI) or lack of Mtb infection. Second, we analyzed
resistance to Mtb infection in the face of continuous exposure, defined by a persistently negative tuberculin skin test (PTST-);
this outcome was contrasted to LTBI. Third, we analyzed an intermediate phenotype, tumor necrosis factor-alpha (TNFa)
expression in response to soluble Mtb ligands enriched with molecules secreted from Mtb (culture filtrate). We conducted a
full microsatellite genome scan, using genotypes generated by the Center for Medical Genetics at Marshfield. Multipoint
model-free linkage analysis was conducted using an extension of the Haseman-Elston regression model that includes half
sibling pairs, and HIV status was included as a covariate in the model. The analysis included 803 individuals from 193
pedigrees, comprising 258 full sibling pairs and 175 half sibling pairs. Suggestive linkage (p,10
23) was observed on
chromosomes 2q21-2q24 and 5p13-5q22 for PTST-, and on chromosome 7p22-7p21 for TB; these findings for PTST- are novel
and the chromosome 7 region contains the IL6 gene. In addition, we replicated recent linkage findings on chromosome
20q13 for TB (p=0.002). We also observed linkage at the nominal a=0.05 threshold to a number of promising candidate
genes, SLC11A1 (PTST- p=0.02), IL-1 complex (TB p=0.01), IL12BR2 (TNFa p=0.006), IL12A (TB p=0.02) and IFNGR2 (TNFa
p=0.002). These results confirm not only that genetic factors influence the interaction between humans and Mtb but more
importantly that they differ according to the outcome of that interaction: exposure but no infection, infection without
progression to disease, or progression of infection to disease. Many of the genetic factors for each of these stages are part of
the innate immune system.
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Introduction
Tuberculosis (TB), caused by the bacterium Mycobacterium
tuberculosis (Mtb), is a significant, global public health problem,
particularly in sub-Saharan Africa, where the prevalence of TB is
increasing dramatically with the rise of the HIV pandemic. One-
third of the world is infected by Mtb [1]. According to the World
Health Organization, almost 8 million new cases of TB occur
annually, with 2 million deaths attributed to the disease each year.
Uganda is one of the world’s 22 highest burden countries with TB,
with an estimated annual risk of tuberculosis infection of 3% and
an annual incidence of new smear positive TB cases of 9.2 per
1000 in an urban setting [2]. An increased understanding of the
host response to Mtb will facilitate the development of new
vaccines and therapeutics [3].
Since only 10% of individuals infected with Mtb go on to
develop active disease (TB), it has been suggested that host genetics
may influence the risk for TB. Early evidence for susceptibility for
TB was suggested by twin studies and difference in susceptibility
observed among different human populations. Numerous candi-
PLoS ONE | www.plosone.org 1 December 2008 | Volume 3 | Issue 12 | e4094date gene studies have been conducted for TB; though there is
consistent support for a role of human genetics in disease risk, the
results for specific genes have been equivocal (reviewed in [4]).
Four genome-wide linkage scans have been conducted [5–8], but
their results did not replicate each other. This may be due to
differences in TB diagnostic criteria, population genetic differences
(Brazilian, Gambian, Malawian and South African), small sample
size, or analytic approach.
The pathogenesis of TB can be thought of as a two-stage
process [9]. The first stage consists of latent Mtb infection (LTBI),
in which Mtb establishes a productive infection but does not
produce symptoms. LTBI is diagnosed by a positive tuberculin
skin test (TST) and/or positive interferon-c response assay (IGRA)
and the absence of clinical signs and symptoms of full-blown
disease [10]. Interestingly, some people remain uninfected,
evidenced by a negative TST and/or negative IGRA, despite
prolonged exposure to an infectious TB case. Negative TSTs
occur even in TB-endemic settings, where exposure to Mtb is
known to be persistent [10]; repeated negative TSTs over several
occasions are even less likely to be false-negatives. These
individuals are thought to be resistant to Mtb infection, but have
not been studied extensively because few studies assess exposure to
an infectious TB case within a home and prospectively conduct
repeat TSTs. Previous studies have shown ethnic differences in the
prevalence of LTBI and the rate of TST conversion [11] and in
the relative permissiveness of macrophages to Mtb infection [12].
Another study showed differences in FOXP3 gene expression
between TST2 and TST+ individuals [13]; however, it was
unknown if those TST2 individuals ever converted their TST,
which is possible since they were contacts of TB cases, so they
cannot be definitively classified as resistant to Mtb infection. These
findings have suggested a role for human genetics in resistance to
Mtb infection [14], but this has not been examined in a formal
genetic epidemiological study. The second stage is TB (disease), in
which Mtb replication and the host immune response disrupts
normal physiology and produces characteristic signs and symp-
toms including productive cough and cavities on chest x-ray. It is
this stage, development of TB, which has been studied in previous
genetic epidemiological studies as well as mouse models.
In our previous studies [15–17], we have taken a unique
approach to the study of TB genetics by studying tumor necrosis
factor-a (TNFa) expression as an intermediate phenotype.
Intermediate phenotypes are more closely tied to underlying
disease biology [18,19]. We have focused on TNFa because it is a
central cytokine in TB pathogenesis that is involved in granuloma
formation, induces symptoms including fever and weight loss
[20,21], and is important in the containment of latent Mtb
infection [22]. Our previous studies have suggested that TNFa
responses to Mtb are strongly influenced by genetic factors
[15,17], and that genes in the TNFa pathway also influence TB
[16]. Genome-wide linkage studies have examined genetic
influences on host immunity, and include studies of immune
response to Mtb [23], IgE levels in asthma [24], and CD4+ and
CD8+ cell levels in healthy persons [25].
Here we present a whole genome scan conducted in a
household contact study of Mtb infection and disease in Kampala,
Uganda. We focused on three phenotypes: persons with TB,
compared to persistent TST2 persons and TST+ LTBI
individuals in their households; resistance to Mtb infection,
compared to persons with LTBI; and TNFa as a continuous
intermediate phenotype, measured on all study subjects. Analysis
of these three phenotypes allowed us to examine the clinical
spectrum from Mtb exposure to pulmonary TB. We hypothesized
that these three distinct phenotypes each would have have unique
genetic influences. This is the first genome scan to be conducted in
Uganda, the largest linkage scan for TB, and the first to study
resistance to Mtb infection.
Results
After data cleaning (Figure 1), we analyzed a total of 193
pedigrees comprising 803 individuals (Table 1). Of these, 95
households were enrolled in Phase I of the study and 98
households were enrolled in Phase II. Both children and adults
were included in the analysis. A total of 160 individuals had
culture confirmed TB, 130 were HIV infected, and 85 were
PTST-. Most of the PTST- and LTBI individuals were not HIV
infected (89.6% and 91%, respectively); slightly more than half
(51.9%) of the TB patients were HIV infected, which is consistent
with our previous study in this population [26] (Table 2). HIV tests
were not conducted for 66 very young children, since they were
not at risk for HIV infection because neither parent was HIV
infected. For linkage analysis, there were 258 full sibling pairs and
175 half sibling pairs.
We compared TNFa levels in the three clinical groups (PTST-,
LTBI, and TB) after covariate adjustment and log-transformation.
Figure 1. Flow diagram showing study sample before and after data cleaning.
doi:10.1371/journal.pone.0004094.g001
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and transformed TNFa values are provided in Figure 2. TNFa
levels differed significantly between TB and both PTST-
(p=0.009) and LTBI (p=0.009) in HIV negative individuals.
TNFa levels did not differ significantly between PTST- and LTBI
(p=0.389). This analysis further illustrates that TNFa expression
varies with TB progression.
Linkage analysis results are summarized in Table 3, which lists
regions attaining significance at the nominal a=0.05 level. In
addition, the information content in those regions, as well as the
candidate genes in the vicinity of these regions, is also listed.
Linkage findings for TNFa levels are provided in two ways: in the
first column, pooled results are provided, and in the second
column, results for Phase II of the study analyzed alone are
provided, since previous results suggested these TNFa phenotypes
were different [15].
Though none of the regions attained genome-wide significance
by conventional standards (p,10
25) [27], three regions attained
suggestive significance (p,10
23). Two of these regions were linked
to PTST-, one on chromosome 2 (p=0.0003) (Figure 3) and
another on chromosome 5 (p=0.0005) (Figure 4). The region on
chromosome 2q21-2q24 is 30 cM long and the region on
chromosome 5p13-5q22 is 50 cM long; neither region contains
any previously characterized candidate genes. A 34 cM long
region on chromosome 7, linked to TB, also attained suggestive
linkage (p=0.0002) (Figure 5); the interleukin (IL)-6 gene resides at
the centromeric end of this region. Though not quite attaining the
suggestive significance threshold, we also observed linkage to TB
on chromosome 20q13 (p=0.002) (Figure 6). This same region,
which was 25 cM long in this analysis, has recently been mapped
in African populations [8] and found to contain genes for
melanocortin 3 (MC3R) and cathepsin 7 (CTSZ). There were no
regions attaining genome-wide significance or suggestive signifi-
cance for TNFa.
In addition, a number of regions were linked at the a=0.05
level to chromosomal regions in which possible TB candidate
genes reside. Since linkage effects may extend up to 20 cM [28],
we also considered linkage results within 20 cM of previously
characterized candidate genes as possible replications. TNFa level,
as assayed in both study phases, was linked to chromosome 1 (total
sample p=0.014, Phase II p=0.006); the linked region (120–
130 cM) is roughly 15 Mb from the interleukin (IL)-12 receptor b2
(IL12RB2). Another region on chromosome 1, extending from 130
through 180 cM, was linked to TB (p=0.01). On chromosome 2
(Figure 3), a region extending from 250 to 260 cM was also linked
to PTST- (p=0.02); this region is approximately 17 Mb from the
location of NRAMP1 (SLC11A1), the most analyzed candidate
gene in TB [29]. A second region on chromosome 2, between 86–
108 cM, was linked to TB (p=0.01); this region contains genes for
the IL-1 complex (IL1, IL1RA, etc.). Another region on
chromosome 2, extending from 54–80 cM, was linked to TNFa
level in the Phase II sample (p=0.02) but, because this region ends
only 6 cM from the region linked to TB, it cannot be distinguished
from the IL1 complex region. Other suggestive linkages to TB
alone were seen on: chromosome 3, in a region containing IL12A
(p=0.02); chromosome 6, in the region containing the MHC
complex and TNFA (p=0.03); and the chromosome 7 and 20
regions mentioned above. Finally, a region on chromosome 21, in
which the gene for IFNc receptor 2 (IFNGR2) resides, was linked to
TNFa levels from the whole sample (p=0.009) and TNFa from
Phase II (p=0.01).
Several other regions attained linkage at the a=0.05 level, but
did not contain any previously characterized TB candidate genes.
One region on chromosome 2, extending from 120–128 cM, was
linked to PTST- (p=0.007), and a second region ,18 cM away,
extending from 146–176 cM, was also linked to PTST-
(p=0.0003). Markers on the short arm of chromosome 8 were
linked to all three phenotypes in the region between 32 and
72 cM, though only TNFa levels from the whole sample attained
significance with p,0.01. Linkage to this chromosome 8 region
has been previously reported in a Moroccan study population
Table 1. Descriptive statistics for final analysis sample.
Total number of individuals 803
Numbers of females/males 435/368
Median age (range) 15.00 (1–80)
Number of individuals with TB 160
Number of PTST- individuals 85
Number of HIV infected individuals 130
Number of households 193
Median pedigree size (range) 4.00 (2–24)
Number of full sibling pairs 258
Number of half sibling pairs 175
doi:10.1371/journal.pone.0004094.t001
Table 2. Clinical group by HIV status.
HIV negative HIV positive
PTST- 69 8
LTBI 455 45
TB 83 77
HIV tests were not conducted for 66 children because they were not clinically
relevant.
doi:10.1371/journal.pone.0004094.t002
Figure 2. Boxplot of covariate-adjusted and log-transformed
TNFa across stage of Mtb infection and disease. This boxplot
displays the median and distribution of TNFa values across the three
clinical groups. PTST-=persistent TST negative (resistant to Mtb
infection), LTBI=latent Mtb infection (TST positive, no disease),
TB=tuberculosis (disease).
doi:10.1371/journal.pone.0004094.g002
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characterized.
To explore whether these results were confounded by the
presence of HIV positive individuals in the analysis, we repeated
the genome scan by restricting the analysis to sibling pairs that
were concordantly HIV negative (Table 4). In general, most of the
significant results remained, though some candidate regions were
no longer significant or less significant in this restricted analysis. A
few regions actually increased in their statistical significance. It is
likely that the fluctuations in p-values were due to reductions in
sample size for these analyses of subpopulations. Finally, we note
that the information content, which is a measure that depends on
the informativity of both the markers and the trait being analyzed,
is 0.72.
Discussion
In this report, we present a full genome scan of a Ugandan
population with different responses to Mtb exposure and infection.
To our knowledge, this is the largest sample from a TB-endemic
population analyzed with a full genome-wide linkage scan. Also,
this analysis includes both HIV positive and negative individuals,
so these findings are relevant to a general population. This is also
the first investigation of a novel phenotype, PTST-, which is an
indication of resistance to Mtb infection. We found that two novel
regions, on chromosomes 2q21-2q24 and 5p13-5q22, attained
suggestive genome-wide significance to PTST-. There may also be
a second novel region on chromosome 2q14, which is close
enough to 2q21-2q24 that it cannot be distinguished using sib-pair
linkage analysis [28]. Since these regions have not been linked to
TB in previous studies, future studies will focus on fine mapping
these regions. We have also replicated the recent linkage findings
of Cooke et al. [8], thus providing the first replication report of the
newly published TB candidate genes, CTSZ and MC3R.B y
examining distinct phenotypes that represent different stages of the
natural history of Mtb infection, we demonstrate that these
different stages (i.e. exposure, infection, disease) have distinct
genetic influences that underlie the likely different biological
mechanisms involved in resistance to infection vs. controlling
latent infection vs. progression to active pulmonary TB.
This report provides the first investigation of individuals who
have persistently negative TSTs over time despite prolonged and
persistent exposure to infectious individuals with TB. Previous
studies have suggested that host genetics may play a role in
Table 3. Chromosomal regions significant at the a=0.05 level by trait.
Chromosomal
region cM range
a
Marker information
(range) Most significant p-value by trait Genes in vicinity/Notes
TB PTST- TNFa (meta)
b TNFa (Phase II)
b
1p31 120–130 .72–.80 0.014 0.006 15 Mb from IL12RB2
1p21-1q24 130–180 .71–.80 0.02
2p22-2p16 54–80 .68–.80 0.02
2p13-2q11 86–108 .72–.81 0.02 IL1 complex
2q14 120–128 .75–.76 0.007
2q21-2q24 146–176 .68–.75 0.0003
2q27 250–260 .73–.80 0.02 17 Mb from SLC11A1
3q23 150–168 .73–.75 0.02 IL12A
5p13-5q22 64–114 .69–.77 0.0005
6p21 36–50 .76–.86 0.03 TNF/MHC
7p22-7p21 0–34 .68–.82 0.0002 IL6
7q35-7q36 158–172 .51–.57 0.02
8p22 32–40 .57–.73 0.04 Linked in Morrocan study[30]
8p12-8q11 64–72 .73–.77 0.001 0.02 0.02
8q21-8q23 104–124 .64–.75 0.010 0.02
9p21-9q12 54–66 .72–.78 0.02
10q24-10q24 121–163 .57–.81 0.02
11p15 0–16 .69–.73 0.02
11q14-11q23 88–118 .72–.84 0.034 0.007
14p13-14q11 2–24 .51–.77 0.02
14q21-14q24 55–82 .64–.83 0.02
19p13-19q12 40–54 .75–.76 0.006
20q13 64–89 .47–.65 0.002 MC3R and CTSZ
21q22 38–44 .56–.62 0.009 0.01 IFNGR2
22p13-22q11 2–46 .65–.76 0.02 0.02
cM=centimorgans, Mb=Megabases.
P-values in boldface indicate results attaining suggestive significance according to Lander-Kruglyak criteria.
acM range indicates locations significant at the nominal a=0.05 level.
bThe first column of linkage results for the TNFa phenotype are for pooled p-values, and the second column is for the Phase II data analyzed alone.
doi:10.1371/journal.pone.0004094.t003
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phenotype with any underlying genotype. This study of resistance
to Mtb infection therefore provides insight into an early stage of
the natural history of disease progression. Since our study is the
first to focus on this end of the spectrum of the natural history of
Mtb exposure and infection, it is not surprising that we have
identified linkage findings that are new to the TB literature. It is
very likely that host genetic and immunologic responses differ
between resistance to infection, containment of initial Mtb
infection and progression of latent Mtb infection to active
pulmonary TB. All genetic epidemiological studies of TB to date
have focused entirely on the genetic influences underlying the
development of disease. Furthermore, since our study observed
households over a period of two years, we were uniquely poised to
assess the PTST- phenotype. Though it is possible that individuals
may convert their skin test beyond this period of observation, it is
Figure 3. Plot of linkage results for chromosome 2. 2log10(p-value) from the linkage analysis of each trait is plotted against marker location.
This plot illustrates that different TB phenotypes were linked to different regions on chromosome 2.
doi:10.1371/journal.pone.0004094.g003
Figure 4. Plot of linkage results for chromosome 5. 2log10(p-value) from the linkage analysis of each trait is plotted against marker location.
doi:10.1371/journal.pone.0004094.g004
Genome Scan of TB in Uganda
PLoS ONE | www.plosone.org 5 December 2008 | Volume 3 | Issue 12 | e4094very unlikely; in our study we observed that most adult TST
negative household contacts converted their skin tests within
3 months of study enrollment (,67%, unpublished data). We
observed linkage between this phenotype and several chromo-
somal regions, some of which were novel, while others – like
SLC11A1 – have been studied extensively. Though the role of
SLC11A1 in murine models of TB is well-established, studies of
human TB have revealed inconsistent results, and thus its role in
the disease phenotype remains controversial [29]. Since we
observed linkage between this gene region and PTST-, and not
TB, our results may provide a further clue into the role of this gene
in the natural history of Mtb infection.
In addition, we observed linkage at the a=0.05 level to several
regions containing potential TB candidate genes. Some of these
qualify as replications of previous genetic associations using
genome-wide criteria [27]. We detected linkage to a region
containing the IL6 gene. IL6 is known to have both pro- and anti-
inflammatory properties in TB [31] and IL6 knock-out mice
Figure 5. Plot of linkage results for chromosome 7. 2log10(p-value) from the linkage analysis of each trait is plotted against marker location.
doi:10.1371/journal.pone.0004094.g005
Figure 6. Plot of linkage results for chromosome 20. 2log10(p-value) from the linkage analysis of each trait is plotted against marker location.
doi:10.1371/journal.pone.0004094.g006
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find an association between IL6 and TB [33]; our study is the first
to suggest an association. We also observed linkage to the region
containing the IL1 complex of genes, with TB as the phenotype;
IL1B has been associated with TB in Japanese [34], Gambian [35]
and Columbian [36] study populations, while IL1RA has also been
associated with TB in a Gambian population [37]; both genes
were associated with pleural TB in a Gujarati Hindu population in
England [38]. Additionally, we observed linkage to regions
containing genes within the interferon-c (IFNc)/interleukin (IL)-
12 pathway, including IL12RB2, IL12A and IFNGR2. Though
deficiencies in IFNGR2 have been associated with disseminated
non-tuberculous mycobacterial disease [39,40], this gene was not
associated specifically with TB in a case-control study [41]. In the
present analysis, IFNGR2 was linked to TNFa expression levels,
which may be the result of crosstalk between the IFNc and TNFa
pathways [42]. IL12RB2 has been associated with leprosy [43] but
not TB and, to our knowledge, IL12A has not been associated with
TB in any study. Previous genetic epidemiological studies have
found associations between IL12B, IL12RB1 and TB, though not
with IL12A and IL12RB2 [44]. A possible explanation for this
apparent discrepancy could be that risk alleles in IL12A and
IL12RB2 are rare and better detectable by linkage [45]. In our
analysis, IL12RB2 was linked to TNFa expression, which may
reflect the feedback loop between IFNc, TNFa, and IL12 [46].
Finally, we observed linkage between all three traits and the
chromosome 8 region found to be linked to TB in a whole genome
scan in a Moroccan population [30]; our results suggest that this
region may contain multiple genes each linked to the different
stages of the natural history of Mtb infection and disease, or one
gene with pleiotropic effects.
A previous genome scan by Wheeler et al. [23] examined linkage
to TB immune phenotypes; these phenotypes were immunoglobulin
and IFNc responses to various Mtb proteins. We found some
commonality between their results and ours. The study by Wheeler
and colleagues observed linkage to IgG responses to purified protein
derivative (PPD) on chromosome 3q23 (p=0.008) and also linkage to
IFNc responses to PPD, both on chromosome 1q24 (p=0.0009) and
chromosome 19q12 (p=0.007). In our analysis, the chromosome
1q24 and 3q23 regions were linked to TB and chromosome 19q12
was linked to TNFaresponses. This further illustrates the roleof these
chromosomalregionsinimmunityrelatedtoTBandwarrantsfurther
investigation.
Though our previous candidate gene analysis [16] demonstrat-
ed that some genes were linked to both TNFa and TB, very few
regions were linked to multiple traits in this genome scan. There
may be several reasons for this. First, the candidate genes in our
previous work were chosen specifically because they were part of
the TNFa pathway and previously associated with TB. Second,
the markers in that study were more densely spaced so that those
specific genes were being targeted. And finally, linkage for one
trait may not have the same statistical power as for another.
Conversely, the present agnostic analysis did not target genes in
any specific pathway. Interestingly, several of these candidate
Table 4. Chromosomal regions significant at the a=0.05 level by trait for analysis of HIV concordantly negative sibling pairs.
Chromosomal region cM range
a Marker information (range) Most significant p-value by trait Genes in vicinity/Notes
TB PTST- TNFa (meta)
b TNFa (Phase II)
b
1p31 120–130 .72–.80 0.02 0.006 15 Mb from IL12RB2
1p21-1q24 130–180 .71–.80 0.01
2p22-2p16 54–80 .68–.80 0.01
2q14 120–128 .75–.76 0.003
2q21-2q24 146–176 .68–.75 0.0003
2q27 250–260 .73–.80 0.03 17 Mb from SLC11A1
5p13-5q22 64–114 .69–.77 0.003
7p22-7p21 0–34 .68–.82 0.002 IL6
7q35-7q36 158–172 .51–.57 0.01
8p12-8q11 64–72 .73–.77 0.02
8q21-8q23 104–124 .64–.75 0.005 0.02
9p21-9q12 54–66 .72–.78 0.007
10q24-10q24 121–163 .57–.81 0.04
11p15 0–16 .69–.73 0.03
11q14-11q23 88–118 .72–.84 0.003 0.003
14p13-14q11 2–24 .51–.77 0.006
14q21-14q24 55–82 .64–.83 0.02
19p13-19q12 40–54 .75–.76 0.007
20q13 64–89 .47–.65 0.02 MC3R and CTSZ
21q22 38–44 .56–.62 0.0005 0.01 IFNGR2
22p13-22q11 2–46 .65–.76 0.007 0.02
cM=centimorgans, Mb=Megabases.
P-values in boldface indicate results attaining suggestive significance according to Lander-Kruglyak criteria.
acM range indicates locations significant at the nominal a=0.05 level.
bThe first column of linkage results for the TNFa phenotype are for pooled p-values, and the second column is for the Phase II data analyzed alone.
doi:10.1371/journal.pone.0004094.t004
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with TNFa in the present study, including IL12RB2, NRAMP1
(SLC11A1), IFNGR2, and the region on chromosome 8 identified
by El Baghdadi et al. [30]. This linkage between TB genes and
TNFa lends further support to our intermediate phenotype model.
These results further support that progression of Mtb infection to
disease is a complex trait with likely several underlying distinct
genetic risk factors. This complexity of Mtb infection and disease
likely explains the inconsistency of results across genetic epidemi-
ological studies. In addition, these results imply that the various
stages of the natural history of Mtb infection [9] have unique
genetic influences. These results confirm not only that genetic
factors influence the interaction between humans and Mtb but
more importantly that they differ according to the outcome of that
interaction: exposure but no infection vs. infection but no
progression to disease vs. progression of infection to disease.
Because of missing genotype and phenotype data, this analysis
was limited to 803 individuals, reducing its statistical power.
Furthermore, since TNFa was assayed differently in Phase I and II
of the study, the data could not be pooled, further affecting power.
However, because our results are consistent with current TB
immunologicalmodels,wethinktheyareunlikelytobefalsepositive
findings. This study might have been underpowered to detect genes
with smaller effects, since very large sample sizes are required to
detect small effects using linkage analysis [45]. Another limitation of
the analysis was that empirical p-values could not be computed
because we analyzed both full and half sibling pairs together and
then defining the appropriate permutation distribution becomes
problematic. Future studies will focus on replication in independent
populations using an association strategy. Additional studies will use
focused microarray and immunological approaches to examine the
functional implications of these and other genes.
Materials and Methods
Study design
Families were enrolled through the Household Contact Study
[26] in Kampala, Uganda. The first phase of the study enrolled
households from 1995 through 1999 ascertained through index TB
patients who presented totheNational TBandLeprosyProgramme
(NTLP),andhad positiveacid-fastsmear(AFB positive)and positive
Mtb cultures; the household was enrolled if the index case lived with
at least one person and the individuals in the household as well as
theindexcaseprovidedinformedconsenttoparticipateinthestudy.
The second phase of the household contact study started enrolling
patients from 2002 and continues to the present. Written informed
consent was obtained from all individuals in both study phases (or in
the case of children, the child provided assent and his/her legal
guardian provided written consent on their behalf). Ascertainment
in Phase II differed in that index cases were required to be only
culture positive for Mtb and, in addition to referral from the NTLP,
came to the clinic directly after learning about the study through
community sensitization (education) efforts and word-of-mouth.
The index case and household members were observed over a two
year period in order to capture clinical outcomes as described
below. The present analysis of Phase II includes families enrolled
from April 2002 through February 2004. Any individuals who
withdrew consentwere excluded from the analysis.The institutional
review boards at University Hospitals of Cleveland and the Uganda
Council for Science and Technology approved the study.
Clinical characterization and phenotypes
After enrollment in the study, all household members were
given a full clinical examination, including testing for HIV.
Individuals who were suspected to have pulmonary TB received a
chest x-ray, and provided sputum samples for culture and AFB
smear, or gastric aspirates in the case of young children. Diagnosis
of TB disease in contacts was based on ATS criteria [10]; all
individuals diagnosed with active TB disease received standard TB
therapy for 6 months. In this analysis, ‘‘TB case’’ refers to all
individuals with culture-confirmed TB [10]; this includes the index
case, co-prevalent cases (diagnosed within 3 months of enroll-
ment), and incident cases (development of TB more than 3 months
after baseline study assessment).
Tuberculin skin testing (TST) was done for all individuals in the
home, using purified protein derivative (PPD) with the Mantoux
method. A positive TST was defined as an induration of 5 mm or
greater in children less than or equal to 5 years of age or in HIV
positive individuals, or an induration of 10 mm or greater in HIV
negative individuals aged greater than 5 years. Skin tests were
repeated 3, 6, 12, and 24 months after enrollment in individuals
who were TST negative at baseline assessment. A persistently
negative TST (PTST-) was defined as a negative skin test on two
or more occasions over 2 years of observation in an individual who
had been living with the index case. By our definition, these
individuals did not go on to develop TB. Individuals who had a
negative TST at the time of study enrollment but converted to a
positive TST during study follow-up were included in the LTBI
group for this analysis. In Phase II of the household contact study,
all individuals with positive TST results were offered Isoniazid
preventative therapy.
In addition to these clinical outcomes, we also examined
cytokine production by whole blood stimulation with soluble Mtb
ligands enriched for molecules secreted by Mtb (culture filtrate).
Whole blood was stimulated with culture filtrate (10 mg/ml),
incubated for 24 hours, and TNFa measured by ELISA in culture
supernatant. Additional details regarding the methods for these
assays can be found elsewhere [15,17]. This study measured
TNFa expression in response to Mtb culture filtrate proteins and
glycolipids.
Data analysis
Prior to further analysis, TNFa expression variables were
adjusted for demographic differences between study cohorts [15].
To examine differences in TNFa between individuals PTST-, with
latent Mtb infection (LTBI), and TB, we used nonparametric
methods since TNFa values were still not normally distributed
even after covariate adjustment and log transformation. This
analysis was restricted to HIV negative individuals only so that
results would not be confounded by immunosuppresion. Since the
ELISA kit and source of culture filtrate differed between Phase I
and II of the study [15], we conducted linkage analysis for the
TNFa variable separately by study cohort and then combined p-
values using Fisher’s method [47]; we present the pooled results
and results for Phase II alone since the latter data were more
complete [16]. Since our diagnosis of TB and PTST- did not differ
by study phase, we combined the cohorts for those analyses.
Molecular methods
DNA was obtained from buffy coat specimens extracted from
blood samples taken as part of the study; further detail about DNA
preparation is described elsewhere [16]. A microsatellite genome
scan was conducted by the Mammalian Genotyping Service at the
Center for Medical Genetics in Marshfield, Wisconsin. Four
hundred microsatellite markers (Screening Set 16), with an
average intermarker spacing of 9.04 cM, were genotyped across
the 22 autosomes, chromosome X, and chromosome Y for 828
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There were several steps involved in genotype cleaning. Eleven
of the 400 markers were removed from the analysis because they
were in significant Hardy-Weinberg disequilibrium among the
founders (p,0.0001), using the method of Montoya-Delgado et al.
[48]. We genotyped 18 subjects in duplicate in order to estimate a
genotype error rate. The proportion of discordant genotypes in the
replicate samples was 0.417%, across all 400 markers. No marker
showed large discrepancies compared with any other and no
individual sample showed higher error rates compared with any
other. Discordant genotypes were deleted prior to further analysis.
In addition, Marshfield blindly genotyped DNA samples for
estimating typing error, and arrived at an estimated 0.63% rate,
most of which were 1 base shifts in allele size. With the genotype
data itself, Marshfield provided a number of reports, some of
which flagged alleles that were unexpected from the assay (e.g.
more or less repeats than had been seen in previous study
populations, putative ‘‘null’’ alleles). Alleles at four of these
markers segregated within families, so they were retained in the
analysis, but the remainder were treated as genotype errors and
deleted from the analysis.
Then, we validated pedigree structures using RELTEST [49]
and RELPAIR [50] (Figure 1). When these methods identified
relationships inconsistent with the molecular data, we queried the
on-site staff in Uganda to clarify these relationships. If the
molecular data were still inconsistent with the reported relation-
ship, the individual in question was removed from the analysis
(N=13). We also confirmed gender as reported in the database
with X and Y chromosome genotypes, and discrepant results were
queried and corrected according to the patients’ clinic charts;
however, some discrepancies were unresolvable for these individ-
uals and their genotypes were deleted from the analysis (N=12)
since DNA contamination or poor quality was suspected. Finally,
Mendelian inconsistencies were detected using MARKERINFO
(S.A.G.E. v5.3), and inconsistent genotypes were deleted from the
data using PedScrubber (courtesy of Dr. Robert Igo, Jr.). In total,
13.6% of the genotypes (including Mendelian errors and poor
quality genotypes) were coded as missing. Marker map locations
were based on the Screening Set 16 map. Because chromosome 8
inversions have been reported in some populations [51], we
verified our chromosome 8 marker order by conducting two-point
marker-to-marker linkage analysis using LODLINK (S.A.G.E.
v5.3); this analysis demonstrated that the published marker order
was correct (data not shown).
Statistical genetic analysis
Prior to further analysis, we examined the autosomal marker
data for population substructure, since the households were
enrolled in two different time periods with slightly different
ascertainment criteria. We used the STRUCTURE program [52]
to attempt to cluster together families with similar subpopulation
allele frequencies. This approach has been used successfully in a
family study of African Americans to partition families into
subpopulations [53]. We attempted 2, 3, and 4 subpopulations,
but families did not fall into clusters. Since this analysis supports
genetic homogeneity within our study population, we analyzed the
data together.
Multipoint analysis of the autosomes and X chromosome was
conducted using a model-free approach. Marker allele frequencies
in the founders were estimated using FREQ (S.A.G.E. V5.3), and
the proportion of alleles shared identical by descent by each
relative pair was estimated using GENIBD (S.A.G.E. v5.3).
Linkage analysis was conducted using the Haseman-Elston
method [54,55], which regresses a measure of sibpair trait
similarity on the proportion of alleles shared identical by descent.
Though a quantitative trait linkage method, this model is also
applicable for binary traits such as TB and PTST-. This method,
as implemented in SIBPAL (S.A.G.E. v5.3), has been recently
extended to also incorporate half sibling pairs [56]. Originally, the
measure of sibling pair trait similarity was parameterized as the
trait difference squared [55]; in recent years, this method was
extended to model the dependent trait as the mean-corrected
sibpair trait sum [54], and a weighted combination of these two
[57], the latter method being referred to as ‘‘W4’’ within SIBPAL.
Since trait variance, heritability, and ascertainment method all
have an impact on the ‘‘best’’ parameterization of the dependent
trait [58], we analyzed the three phenotypes using the original
difference squared and W4 options; in all cases, the binary trait
analyses were most significant using the difference squared option
because of the relatively small number of concordantly affected
pairs, while the results for TNFa were most significant using the
W4 option. We also included HIV status as a covariate,
parameterized as the sibpair sum, in all Haseman-Elston
regression models to account for variability due to HIV
seropositivity. Genome-wide statistical significance was deter-
mined using standard criteria [27]; extent of linked region is
reported for markers significant at a=0.05. Information content
within linked regions was evaluated using the method proposed by
Krugylak et al. [59], as implemented in MLOD (S.A.G.E. v5.3).
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